Nexscient Q3 FY26 net loss narrows 6% to $127,231; revenue remains none

NEXSCIENT INC

NEXSCIENT INC

NXNT

0.00
  • Nexscient posted a net loss of $127,231 for the quarter ended March 31, 2026, narrowing 6%.
  • Operating expenses rose 7% to $115,469, including $7,000 in research and development spending; revenue remained at no revenue.
  • Cash on hand was $754,990 as of March 31, 2026, with accumulated net loss at $2 million.
  • Management pegged cash burn at about $27,500 per month, estimating available resources net of a $600,000 acquisition cash requirement could fund operations for a maximum of six months.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nexscient Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001477932-26-003217), on May 15, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.